oncodaily - Fox Chase Cancer Center shared a post on LinkedIn: “Temple Health – Temple University Health System today announced the appointment of Dr. Rob Winn, MD, as the next Cancer Center […]
AI Summary: Rob Winn has been appointed director of the NCI‑designated Fox Chase Cancer Center, taking the reins of clinical, research and strategic operations. His role will focus on strengthening translational research, patient care integration and institutional partnerships to advance the center's mission — you know, the usual: cure more cancer, argue less in committee meetings.
St. Jude names Charles Roberts next president and CEO / 7 days
Small study reports 100% one‑year survival after lung transplant / 7 wks
High‑dose targeted radiation shows promise for huge bile duct tumors / 4 months
Introducing ISCO 2026 chairs and program highlights / 4 months
ASTRO issues 2026 radiation guideline update for pancreatic cancer / 14 days
Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 3 months
ESMO issues new metastatic colorectal cancer clinical guideline / 4 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.